Skip to content

A Social Network Approach to Improve HIV Prevention and Substance Use Treatment For People Who Use Drugs

A Social Network Approach to Improve HIV Prevention and Substance Use Treatment For People Who Use Drugs

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07409350
Enrollment
398
Registered
2026-02-13
Start date
2027-01-01
Completion date
2028-12-01
Last updated
2026-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Prevention, Substance Use

Brief summary

This study includes finalization of the LINKED social network intervention to improve PrEP and MOUD uptake among people who inject drugs (PWID) in collaboration with an Expert Advisory Board and staff (N=16) at The Sidewalk Project (TSP), followed by a Hybrid Type II cluster randomized trial of the LINKED intervention (versus an equal-attention control) among N=372 people who inject drugs, with 6- and 12-month follow-up assessment of PrEP and MOUD uptake. The investigators will also evaluate implementation outcomes to inform future sustainable implementation of LINKED in harm reduction organizations.

Interventions

BEHAVIORALLINKED

LINKED is a theory-driven social network intervention (SNI) that leverages peer influence within the social networks of people who inject drugs (PWID) to disseminate information, encourage communication, and increase pre-exposure prophylaxis (PrEP) and medications for opioid use disorder (MOUD) uptake and persistence in harm reduction organization (HRO) settings.

Group intervention facilitated by trained study staff that supports critical thinking about what constitutes low, medium, and high risks for HIV and overdose.

Sponsors

NYU Langone Health
Lead SponsorOTHER
National Institute on Drug Abuse (NIDA)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Aim 1 - Virtual Focus Group * Is 18 years or older * Is a current TSP staff * Is capable and willing to provide consent Aim 2 - Intervention * 18 years or older * Spend majority of their time in the Los Angeles, CA area where recruited * Able to complete surveys and group sessions in English * Self-report to have injected drugs in the past 3 months * Self-reported HIV negative serostatus * Not currently on PrEP or MOUD * Not pregnant * If a network recruit: presents a valid recruitment coupon * Is capable and willing to provide consent Aim 3 - Virtual Focus Group/Surveys * Is 18 years or older * Is a current TSP staff * Is capable and willing to provide consent

Exclusion criteria

Aims 1 and 3: • Individuals who are not current TSP staff members will be excluded from participation. Aim 2: * Under age 18; * Does not spend majority of time in the Los Angeles, CA area where recruited; * Unable to complete surveys and groups sessions in English; * Does not self-report injecting drugs in past 3 months; * Self-reported HIV positive serostatus * Currently on PrEP or MOUD * Currently pregnant * If a network recruit: does not present a valid recruitment coupon

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Participants with PrEP UptakeMonth 6Measured via filled PrEP prescription.
Percentage of Participants with MOUD UptakeMonth 6Measured via filled MOUD prescription or buprenorphine, methadone, or naltrexone enrollment.
Percentage of Participants with PrEP AdherenceMonth 6Measured via urine immunoassays to test for oral PrEP.
Percentage of Participants with MOUD AdherenceMonth 6Measured via urinalysis to test for metabolites for MOUD.

Countries

United States

Contacts

CONTACTSuzan Walters, PhD
Suzan.Walters@nyulangone.org951-443-6351
PRINCIPAL_INVESTIGATORSuzan Walters, PhD

NYU Langone Health

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026